Related by context. Frequent words. (Click for all words.) 76 Shareholder Letter 72 Provides Guidance 72 Updates Shareholders 71 Q2 Loss Narrows 71 1st Quarter Results 71 Q3 Loss Narrows 71 Upcoming Conferences 71 Announces Stockholder Approval 71 3rd Quarter Results 70 Annual Meeting Date 70 Share Repurchases 70 Q1 Loss Narrows 70 Drug Resistant 70 Shareholder Opinions 70 Patient Enrollment 70 2nd Quarter Results 70 Explore Strategic Alternatives 70 Provides Updates 70 Q4 Loss Widens 69 Smallpox Vaccine 69 Complete Merger 69 Revenues Decline 69 Q2 Loss Widens 69 Preliminary Third Quarter 69 Summarizes 69 Shareholder Update 69 FY# Guidance 69 Preliminary Fourth Quarter 69 Clinical Trial Results 69 www.syntapharma.com 68 Updates Guidance 68 Commence Trading 68 Q4 Loss Narrows 68 Q3 Loss Widens 68 Joins OTCQX 68 Cash Dividends 68 Files Annual Report 68 Inc Therapeutic Competitors 68 Option Grants 68 Presents Positive 68 FDA Clears 68 Stockholders Approve Merger 68 Shareholder Lawsuit 68 Drug Candidate 67 Adopts Shareholder Rights 67 From Recent Editorials 67 www.safeguard.com 67 Upcoming Investor Conference 67 Completes Tender Offer 67 Completes Enrollment 67 www.clda.com 67 Forecast Quick Facts 67 Q1 Loss Widens 67 Commences Trading 67 IIROC Resume 67 #.#/Share [002] 67 www.dundeereit.com 67 www.Navistar.com newsroom 67 Reaffirms Guidance 67 Extends Tender Offer 67 Declares Increased 67 Releases Third Quarter 67 Hold Third Quarter 67 CFO Resigns 67 Calls Purchased 67 Q4 Profit Surges 67 Record Third Quarter 67 Backs FY# EPS 67 Vertex Pharmaceuticals Announces 67 Reports Profitable 67 Shareholders Approve Merger 67 Announces Share Repurchase 67 Regains Compliance With 66 Q3 Profit Surges 66 CA BUSINESS 66 Reconfirms 66 Holds Annual Meeting 66 Print Issue 66 Before Placing Bids 66 www.labopharm.com 66 Grants Options 66 Completes Private Placement 66 Schedules Fiscal 66 Record Second Quarter 66 Webcast Scheduled 66 Extends Offer 66 Lowers Guidance 66 Two Investor Conferences 66 Provides Preliminary 66 Guides Q4 66 Reduces Risk 66 Dividend Announcement 66 Q2 Profit Surges 66 Announces Presentation 66 Announces Issuance 66 Issues Guidance 66 Guidance Quick Facts 66 Announces Enhancements 66 Fiscal Second Quarter 66 Preclinical Data 66 4Q Loss Widens